Cargando…
Exploring cellular uptake of iron oxide nanoparticles associated with rhodium citrate in breast cancer cells
Nanocarriers have the potential to improve the therapeutic index of currently available drugs by improving their efficacy and achieving therapeutic steady-state levels over an extended period. The association of maghemite–rhodium citrate (MRC) nanoparticles (NPs) has the potential to increase specif...
Autores principales: | Chaves, Natalia L, Estrela-Lopis, Irina, Böttner, Julia, Lopes, Cláudio AP, Guido, Bruna C, de Sousa, Aparecido R, Báo, Sônia N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546771/ https://www.ncbi.nlm.nih.gov/pubmed/28814867 http://dx.doi.org/10.2147/IJN.S141582 |
Ejemplares similares
-
Modulation of fibronectin and laminin expression by Rhodium (II) citrate-coated maghemite nanoparticles in mice bearing breast tumor
por: Rocha, Márcia, et al.
Publicado: (2017) -
Free Rhodium (II) citrate and rhodium (II) citrate magnetic carriers as potential strategies for breast cancer therapy
por: Carneiro, Marcella LB, et al.
Publicado: (2011) -
Acute and subchronic toxicity of the antitumor agent rhodium (II) citrate in Balb/c mice after intraperitoneal administration
por: Carneiro, Marcella L.B., et al.
Publicado: (2015) -
Antitumor effect and toxicity of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles in mice bearing breast cancer
por: Carneiro, Marcella Lemos Brettas, et al.
Publicado: (2013) -
Antitumor effect of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles on mice bearing breast cancer: a systemic toxicity assay
por: Peixoto, Raphael Cândido Apolinário, et al.
Publicado: (2014)